Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer first device shocks but perhaps at a cost, the APPRAISE ATP randomized trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback